immune system
• in CD4+ T cells stimulated with anti-CD3 or cognate peptide, rested then restimulated with anti-CD3 or MOG35-55
• in CD8+ T cells when restimulated
|
• T cells treated with anti-CD3 or MOG35-55 are resistant to development of anergy
|
• delayed onset and reduced severity of MOG-induced experimental autoimmune encephalomyelitis
|
hematopoietic system
• in CD4+ T cells stimulated with anti-CD3 or cognate peptide, rested then restimulated with anti-CD3 or MOG35-55
• in CD8+ T cells when restimulated
|
cellular
• in CD4+ T cells stimulated with anti-CD3 or cognate peptide, rested then restimulated with anti-CD3 or MOG35-55
• in CD8+ T cells when restimulated
|